Breaking the Cycle of Bacterial Growth and Resistance

An Innovative Biotech Company in Boulder, CO.

Crestone is a Boulder, Colorado based clinical stage biopharmaceutical company developing new drug candidates with entirely novel mechanisms. Our research pipeline includes: C. diff treatment, antibiotic-resistant Gram-positive infection treatments, Tuberculosis treatments, and more.

See our progress


Learn about us

Our Company

Get the latest news

Press Releases

Get to know us

Our Team

Who We Are

Boulder, Colorado-based Crestone, Inc. is a clinical stage biopharmaceutical company focused on inventing and developing novel mechanism of action small molecule drugs for serious bacterial infections. Our pipeline includes antibacterial agents aiming to treat a variety of serious conditions caused by antibacterial-resistant microbes, from C. difficile infection to MRSA, tuberculosis, and more.

Our Pipeline

Our R&D pipeline includes several programs that address areas of significant and growing unmet medical need, such as C. diff infection, all with novel mechanism of action agents.

Knowledge Portal

Become a Part of Our Projects

Interested in helping further our research into novel antibacterial agents? We’d be thrilled to have your help, either as an investoror a team member.


Have a question or comment? Follow the link below to contact us about general inquiries.


Find work in a team-oriented environment at one of the leading Colorado pharma companies.


If you're interested in becoming an investor to help fund our research and development, contact us today.